The evidence base demonstrating the benefits of an early focus on palliative care for
patients with serious cancers, including advanced lung cancer, is substantial. Early …

Objectives Financial toxicity is recognized as an important adverse effect of cancer treatment
that may decrease patients' health-related quality of life (HRQOL). We aim to perform a …

Background It has been established that lung cancer is the leading cause of all cancer
deaths. This study sought to analyze the epidemiological trends of lung cancer over the past …

Objectives: To describe financial toxicity (FT) in patients with resected lung cancer and
identify risk factors in this population. Background: FT describes the financial burden …

Background The relationship between treatment-related, cost-associated distress “financial
toxicity”(FT) and quality-of life (QOL) in breast cancer patients remains poorly characterized …

Objective To assess the association between financial toxicity and survival in patients with
head and neck cancer (HNC). Materials and methods Using a single-institution database …

Purpose To quantify financial toxicity of female patients with breast cancer in China and
investigate its factors and patients' coping strategies. Methods The Comprehensive Score for …

Current models of financial burden after cancer do not adequately define types of financial
burden, moderators or causes. We propose a new theoretical model to address these gaps …

Objective To evaluate disparities in financial toxicity and psychological distress in patients
with cancer as a function of treatment and reveal the relationship between financial toxicity …

Context Financial toxicity is a priority concern faced by cancer patients and oncology
providers. A validated instrument is important to measure this toxicity and improve health …